Case | HBS Case Collection | March 2014 (Revised June 2014)

Martini Klinik: Prostate Cancer Care

by Michael E. Porter, Jens Deerberg-Wittram and Clifford Marks

Abstract

Since its establishment in 2005, Hamburg's Martini Klinik had single-mindedly focused on prostate cancer care with a commitment to measure long-term health outcomes for every patient. A wholly owned subsidiary of the Hamburg University Hospital, Martini was a "hospital in a hospital" in close proximity to other hospital departments and services. By 2013, Martini Klinik had become the largest prostate cancer treatment program in the world with 5,000 outpatient cases and more than 2,200 surgical cases annually, with patients coming from all over Germany and from other countries. However, German private insurers were cutting reimbursement for prostate cancer by 15 percent, and denying extra payment for some new procedures, while reimbursement by public health plans was not covering costs. Dr. Hartwig Huland, Martini's founder and Medical Director, was considering how to respond.

Keywords: health care; Germany; Michael Porter; Jens Deerberg-Wittram; Clifford Marks; prostate cancer; health care policy; value agenda; integrated practice units; outcomes measurement; Value; Health Disorders; Insurance; Medical Specialties; Outcome or Result; Business Processes; Insurance Industry; Health Industry; Germany;

Citation:

Porter, Michael E., Jens Deerberg-Wittram, and Clifford Marks. "Martini Klinik: Prostate Cancer Care." Harvard Business School Case 714-471, March 2014. (Revised June 2014.)